Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Transversus Abdominis Plane (TAP) Block in Autologous Breast Reconstruction Donor Site: A Randomized, Double-blind, Placebo-controlled Trial

NCT01398982 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01398982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01398982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Transversus Abdominis Plane (TAP) Block in Autologous Breast Reconstruction Donor Site: A Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2011
Completion date
February 28, 2014
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal/ donor site, diep or free ms-tram breast reconstruction, local pain management, transversus abdominis plane (tap) block catheter